Cardiovascular syphilis, unspecified
ICD-10 A52.00 is a billable code used to indicate a diagnosis of cardiovascular syphilis, unspecified.
Cardiovascular syphilis is a late manifestation of syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. This condition can lead to serious cardiovascular complications, including aortitis, aortic regurgitation, and coronary artery disease. The unspecified designation indicates that the specific cardiovascular manifestations are not detailed in the medical record. Patients may present with symptoms such as chest pain, heart murmurs, or signs of heart failure. Diagnosis typically involves serological testing for syphilis, including non-treponemal tests (e.g., RPR, VDRL) and treponemal tests (e.g., FTA-ABS). Treatment usually involves the administration of benzathine penicillin G, which is effective in eradicating the infection and preventing further complications. Regular follow-up and monitoring are essential to assess treatment efficacy and manage any cardiovascular sequelae. Contact tracing is crucial for preventing further transmission of syphilis, as it is highly contagious and can lead to severe health outcomes if left untreated.
Detailed history of syphilis infection, treatment history, and cardiovascular assessment.
Patients presenting with cardiovascular symptoms and a known history of syphilis.
Ensure comprehensive documentation of serological tests and cardiovascular evaluations.
Thorough cardiovascular examination findings and any relevant imaging studies.
Patients with chest pain and a history of syphilis requiring cardiac evaluation.
Document any cardiovascular interventions or treatments related to syphilis.
Used to confirm syphilis diagnosis in patients with cardiovascular symptoms.
Document the reason for testing and results.
Infectious disease specialists should ensure comprehensive testing.
Common symptoms include chest pain, heart murmurs, and signs of heart failure. Patients may also experience fatigue and palpitations.
Diagnosis is made through a combination of clinical evaluation, serological testing for syphilis, and imaging studies to assess cardiovascular involvement.
